Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
01/05 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 39.97L | |
+8.47% | 483.63Cr | |
+6.62% | 161.09Cr | |
+35.44% | 126.98Cr | |
+31.57% | 91Cr | |
+82.85% | 88Cr | |
+20.73% | 63Cr | |
-28.34% | 53Cr | |
-.--% | 15Cr | |
+18.97% | 13Cr |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Cullinan Oncology Q1 Net Loss Narrows